BD created a next-generation glass pre-fillable syringe (PFS) that raises the bar for vaccine PFS performance, with new and stronger requirements for processability, cosmetics, contamination, and integrity. In order to fulfill the complicated and changing needs of vaccine manufacture, the innovative BD EffivaxTM Glass Prefillable Syringe was created in partnership with top pharmaceutical companies.
Terumo India introduced FineGlide, a sterile pen needle for individuals who require routine insulin injections or other self-medication, by improving patient comfort and consequently drug compliance, FineGlide is the first item from Terumo Medical Care Solutions' Life Care Solutions to be released in India with a high-grade silicone surface and a 3-bevel design, it is a gentler and more comfortable needle for patients. When compared to other options on the market, it is developed with Thin Wall Technology to ensure a greater flow rate and better penetration while requiring less injection effort. It is available in different sizes ranging from 4 mm to 12.7 mm in length and 29-32 Gauge thickness for a variety of uses and is compatible with the majority of regularly used pen devices in India.
Author Credits: Radhika Gupta, Shivam Bhutani
Report ID: 4983
Published Date: Jun 02, 2023
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Growing prevalence of chronic disorders and the rising adoption of self-injection parental devices across the globe are the major factors driving the market growth.
The market is anticipated to attain a CAGR of 8.18% over the forecast period, i.e., 2023 â€“ 2035.
The major players in the market are Cardinal Health, Allison Medical, Inc., B. Braun SE, Argon Medical Devices, and other major players.
The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.
The market is segmented by product, usability, patient group, type, application, end user, and by region.
The disposable is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Growing risk of needle stick injuries, increasing adoption of alternative drug delivery technologies are estimated to be the growth hindering factors for the market expansion.
The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.